Skip to Content

Procainamide Hydrochloride Injection

Last Updated: December 29, 2017
Status: Resolved

Procainamide Hydrochloride Injection

Products Affected - Description
  • Procainamide Hydrochloride injection, Pfizer
    100 mg/mL, 10 mL vial, 25 count (NDC 00409-1902-01)

Reason for the Shortage
    • Pfizer did not provide a reason for the shortage.
    • Nexus Pharmaceuticals launched procainamide injection in October 2017.
Available Products
  • Procainamide Hydrochloride injection, Amphastar
    100 mg/mL, 10 mL Luer Lock syringe, 5 count (NDC 76329-3399-05)

     
    Procainamide Hydrochloride injection, Nexus Pharmaceuticals
    100 mg/mL, 10 mL multiple dose vial, 10 count (NDC 14789-0900-10)
    500 mg/mL, 2 mL multiple dose vial, 10 count (NDC 14789-0900-02)
     
    Procainamide Hydrochloride injection, Pfizer
    500 mg/mL, 2 mL vial, 25 count (NDC 00409-1903-01)

Estimated Resupply Dates

  • Pfizer has procainamide 100 mg/mL 10 mL vials on back order and the company estimates a release date of late-January 2018.

Updated

December 29 and 18, October 20, September 6, August 15, June 26 and 19, May 18 and 2, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide